Stability of Iowa mutant and wild type Aβ-peptide aggregates.

Autor: Alred, Erik J., Scheele, Emily G., Berhanu, Workalemahu M., Hansmann, Ulrich H. E.
Předmět:
Zdroj: Journal of Chemical Physics; 11/7/2014, Vol. 141 Issue 17, p1-10, 10p, 2 Diagrams, 4 Charts, 2 Graphs
Abstrakt: Recent experiments indicate a connection between the structure of amyloid aggregates and their cy-totoxicity as related to neurodegenerative diseases. Of particular interest is the Iowa Mutant, which causes early-onset of Alzheimer's disease. While wild-type Amyloid β-peptides form only parallel beta-sheet aggregates, the mutant also forms meta-stable antiparallel beta sheets. Since these struc-tural variations may cause the difference in the pathological effects of the two Aβ-peptides, we have studied in silico the relative stability of the wild type and Iowa mutant in both parallel and antiparallel forms. We compare regular molecular dynamics simulations with such where the vis-cosity of the samples is reduced, which, we show, leads to higher sampling efficiency. By analyzing and comparing these four sets of all-atom molecular dynamics simulations, we probe the role of the various factors that could lead to the structural differences. Our analysis indicates that the parallel forms of both wild type and Iowa mutant aggregates are stable, while the antiparallel aggregates are meta-stable for the Iowa mutant and not stable for the wild type. The differences result from the direct alignment of hydrophobic interactions in the in-register parallel oligomers, making them more stable than the antiparallel aggregates. The slightly higher thermodynamic stability of the Iowa mutant fibril-like oligomers in its parallel organization over that in antiparallel form is supported by previous experimental measurements showing slow inter-conversion of antiparallel aggregates into parallel ones. Knowledge of the mechanism that selects between parallel and antiparallel con-formations and determines their relative stability may open new avenues for the development of therapies targeting familial forms of early-onset Alzheimer's disease. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index